Results affirm expectation of a novel mechanism of action targeting astrocyte activation to delay progression...
ROCHESTER, N.Y., July 17, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage...
Company expects to lock database in June andremains on track to report key outcomes later in July. Pepinemab...
Last patient last visit in randomized, double-blind, SIGNAL-AD Phase 2a study of pepinemab treatment for...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.